{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:35:50Z","timestamp":1757309750661,"version":"3.37.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017564","name":"Ci\u00eancia sem Fronteiras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s12035-022-03159-w","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:02:41Z","timestamp":1672012961000},"page":"1733-1745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["QTC-4-MeOBnE Ameliorated Depressive-Like Behavior and Memory Impairment in 3xTg Mice"],"prefix":"10.1007","volume":"60","author":[{"given":"Mariana G.","family":"Fronza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoela","family":"Sacramento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Pratic\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0494-5610","authenticated-orcid":false,"given":"Lucielli","family":"Savegnago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"3159_CR1","doi-asserted-by":"publisher","first-page":"e1117","DOI":"10.1038\/tp.2017.90","volume":"7","author":"OP Almeida","year":"2017","unstructured":"Almeida OP, Hankey GJ, Yeap BB, Golledge J, Flicker L (2017) Depression as a modifiable factor to decrease the risk of dementia. Transl Psychiatry 7:e1117. https:\/\/doi.org\/10.1038\/tp.2017.90","journal-title":"Transl Psychiatry"},{"key":"3159_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fphar.2020.00034","volume":"11","author":"W Wiels","year":"2020","unstructured":"Wiels W, Baeken C, Engelborghs S (2020) Depressive symptoms in the elderly\u2014an early symptom of dementia? A systematic review. Front Pharmacol 11:34. https:\/\/doi.org\/10.3389\/fphar.2020.00034","journal-title":"Front Pharmacol"},{"key":"3159_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archneur.60.5.753","volume":"60","author":"RC Green","year":"2003","unstructured":"Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, Duara R, Kukull WA, Chui H, Edeki T, Griffith PA, Friedland RP, Bachman D, Farrer L (2003) Depression as a risk factor for Alzheimer disease: the MIRAGE study. Arch Neurol 60:753\u2013759. https:\/\/doi.org\/10.1001\/archneur.60.5.753","journal-title":"Arch Neurol"},{"key":"3159_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","volume":"63","author":"RL Ownby","year":"2006","unstructured":"Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D (2006) Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63:530\u2013538. https:\/\/doi.org\/10.1001\/archpsyc.63.5.530","journal-title":"Arch Gen Psychiatry"},{"key":"3159_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jamapsychiatry.2017.0658","volume":"74","author":"DC Steffens","year":"2017","unstructured":"Steffens DC (2017) Late-life depression and the prodromes of dementia. JAMA Psychiat 74:673\u2013674. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.0658","journal-title":"JAMA Psychiat"},{"key":"3159_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/YCO.0b013e32834bb9d4","volume":"24","author":"D Enache","year":"2011","unstructured":"Enache D, Winblad B, Aarsland D (2011) Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24:461\u2013472. https:\/\/doi.org\/10.1097\/YCO.0b013e32834bb9d4","journal-title":"Curr Opin Psychiatry"},{"key":"3159_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40120-019-00148-5","volume":"8","author":"AD Burke","year":"2019","unstructured":"Burke AD, Goldfarb D, Bollam P, Khokher S (2019) Diagnosing and treating depression in patients with Alzheimer\u2019s disease. Neurol Ther 8:325\u2013350. https:\/\/doi.org\/10.1007\/s40120-019-00148-5","journal-title":"Neurol Ther"},{"key":"3159_CR8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4088\/JCP.tk16043ah5c","volume":"78","author":"L Culpepper","year":"2017","unstructured":"Culpepper L, Lam RW, McIntyre RS (2017) Cognitive impairment in patients with depression: awareness, assessment, and management. J Clin Psychiatry 78:1383\u20131394. https:\/\/doi.org\/10.4088\/JCP.tk16043ah5c","journal-title":"J Clin Psychiatry"},{"key":"3159_CR9","doi-asserted-by":"publisher","first-page":"e12107","DOI":"10.1002\/dad2.12107","volume":"12","author":"LI Thompson","year":"2020","unstructured":"Thompson LI, Jones RN (2020) Depression screening in cognitively normal older adults: measurement bias according to subjective memory decline, brain amyloid burden, cognitive function, and sex. Alzheimer\u2019s Dement (Amsterdam, Netherlands) 12:e12107. https:\/\/doi.org\/10.1002\/dad2.12107","journal-title":"Alzheimer\u2019s Dement (Amsterdam, Netherlands)"},{"key":"3159_CR10","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s11064-007-9385-y","volume":"32","author":"BE Leonard","year":"2007","unstructured":"Leonard BE (2007) Inflammation, depression and dementia: are they connected? Neurochem Res 32:1749\u20131756. https:\/\/doi.org\/10.1007\/s11064-007-9385-y","journal-title":"Neurochem Res"},{"key":"3159_CR11","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10571-014-0074-5","volume":"34","author":"R Rodrigues","year":"2014","unstructured":"Rodrigues R, Petersen RB, Perry G (2014) Parallels between major depressive disorder and Alzheimer\u2019s disease: role of oxidative stress and genetic vulnerability. Cell Mol Neurobiol 34:925\u2013949. https:\/\/doi.org\/10.1007\/s10571-014-0074-5","journal-title":"Cell Mol Neurobiol"},{"key":"3159_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ynstr.2018.05.003","volume":"9","author":"K Bisht","year":"2018","unstructured":"Bisht K, Sharma K, Tremblay M-\u00c8 (2018) Chronic stress as a risk factor for Alzheimer\u2019s disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress, Neurobiol. Stress 9:9\u201321. https:\/\/doi.org\/10.1016\/j.ynstr.2018.05.003","journal-title":"Stress"},{"key":"3159_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.molmed.2020.03.010","volume":"26","author":"T Berger","year":"2020","unstructured":"Berger T, Lee H, Young AH, Aarsland D, Thuret S (2020) Adult hippocampal neurogenesis in major depressive disorder and Alzheimer\u2019s disease. Trends Mol Med 26:803\u2013818. https:\/\/doi.org\/10.1016\/j.molmed.2020.03.010","journal-title":"Trends Mol Med"},{"key":"3159_CR14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jagp.2016.04.004","volume":"24","author":"GM Babulal","year":"2016","unstructured":"Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TLS, Fagan AM, Morris JC, Roe CM (2016) Mood changes in cognitively normal older adults are linked to Alzheimer disease biomarker levels. Am J Geriatr Psychiatry 24:1095\u20131104. https:\/\/doi.org\/10.1016\/j.jagp.2016.04.004","journal-title":"Am J Geriatr Psychiatry"},{"key":"3159_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1176\/appi.ajp.2017.17040442","volume":"175","author":"NJ Donovan","year":"2018","unstructured":"Donovan NJ, Locascio JJ, Marshall GA, Gatchel J, Hanseeuw BJ, Rentz DM, Johnson KA, Sperling RA (2018) Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults. Am J Psychiatry 175:530\u2013537. https:\/\/doi.org\/10.1176\/appi.ajp.2017.17040442","journal-title":"Am J Psychiatry"},{"key":"3159_CR16","doi-asserted-by":"publisher","first-page":"e198970","DOI":"10.1001\/jamanetworkopen.2019.8970","volume":"2","author":"C Chan","year":"2019","unstructured":"Chan C, Rosenberg PB (2019) Depression synergy with amyloid and increased risk of cognitive decline in preclinical Alzheimer disease. JAMA Netw Open 2:e198970. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.8970","journal-title":"JAMA Netw Open"},{"key":"3159_CR17","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/brain\/awy050","volume":"141","author":"NP Oxtoby","year":"2018","unstructured":"Oxtoby NP, Young AL, Cash DM, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ, Fox NC, Schott JM, Alexander DC (2018) Data-driven models of dominantly-inherited Alzheimer\u2019s disease progression. Brain 141:1529\u20131544. https:\/\/doi.org\/10.1093\/brain\/awy050","journal-title":"Brain"},{"key":"3159_CR18","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S29716","author":"KS Al-Harbi","year":"2012","unstructured":"Al-Harbi KS (2012) Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence. https:\/\/doi.org\/10.2147\/PPA.S29716","journal-title":"Patient Prefer Adherence"},{"key":"3159_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-017-0273-4","author":"P Li","year":"2017","unstructured":"Li P, Hsiao IT, Liu CY, Chen CH, Huang SY, Yen TC, Wu KY, Lin KJ (2017) Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study. EJNMMI Res. https:\/\/doi.org\/10.1186\/s13550-017-0273-4","journal-title":"EJNMMI Res"},{"key":"3159_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-170001","volume":"59","author":"JR Gatchel","year":"2017","unstructured":"Gatchel JR, Donovan NJ, Locascio JJ, Schultz AP, Becker JA, Chhatwal J, Papp KV, Amariglio RE, Rentz DM, Blacker D, Sperling RA, Johnson KA, Marshall GA (2017) Depressive symptoms and tau accumulation in the inferior temporal lobe and entorhinal cortex in cognitively normal older adults: a pilot study. J Alzheimers Dis 59:975\u2013985. https:\/\/doi.org\/10.3233\/JAD-170001","journal-title":"J Alzheimers Dis"},{"key":"3159_CR21","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1176\/appi.ajp.2013.13040466","volume":"170","author":"J Koppel","year":"2013","unstructured":"Koppel J, Sunday S, Buthorn J, Goldberg T, Davies P, Greenwald B (2013) Elevated CSF tau is associated with psychosis in Alzheimer\u2019s disease. Am J Psychiatry 170:1212\u20131213. https:\/\/doi.org\/10.1176\/appi.ajp.2013.13040466","journal-title":"Am J Psychiatry"},{"key":"3159_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/archpsyc.63.2.161","volume":"63","author":"MA Rapp","year":"2006","unstructured":"Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, Gorman JM, Haroutunian V (2006) Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry 63:161\u2013167. https:\/\/doi.org\/10.1001\/archpsyc.63.2.161","journal-title":"Arch Gen Psychiatry"},{"key":"3159_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1369","author":"L Nie","year":"2017","unstructured":"Nie L, Wei G, Peng S, Qu Z, Yang Y, Yang Q, Huang X, Liu J, Zhuang Z, Yang X (2017) Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer\u2019s disease. BioFactors. https:\/\/doi.org\/10.1002\/biof.1369","journal-title":"BioFactors"},{"key":"3159_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ibror.2017.05.001","volume":"2","author":"X Luo","year":"2017","unstructured":"Luo X, Shui Y, Wang F, Yamamoto R, Kato N (2017) Impaired retention of depression-like behavior in a mouse model of Alzheimer\u2019s disease. IBRO Reports 2:81\u201386. https:\/\/doi.org\/10.1016\/j.ibror.2017.05.001","journal-title":"IBRO Reports"},{"key":"3159_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.10.002","author":"MG Fronza","year":"2021","unstructured":"Fronza MG, Baldinotti R, Fetter J, Gon\u00e7alves Rosa S, Sacramento M, Wayne Nogueira C, Alves D, Pratic\u00f2 D, Savegnago L (2021) Beneficial effects of QTC-4-MeOBnE in an LPS-induced mouse model of depression and cognitive impairments: the role of blood-brain barrier permeability, NF-\u03baB signaling, and microglial activation. Brain Behav Immun. https:\/\/doi.org\/10.1016\/j.bbi.2021.10.002","journal-title":"Brain Behav Immun"},{"key":"3159_CR26","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1021\/acschemneuro.9b00661","volume":"11","author":"MG Fronza","year":"2020","unstructured":"Fronza MG, Baldinotti R, Fetter J, Sacramento M, Sousa FSS, Seixas FK, Collares T, Alves D, Pratic\u00f2 D, Savegnago L (2020) QTC-4-MeOBnE rescues scopolamine-induced memory deficits in mice by targeting oxidative stress, neuronal plasticity, and apoptosis. ACS Chem Neurosci 11:1259\u20131269. https:\/\/doi.org\/10.1021\/acschemneuro.9b00661","journal-title":"ACS Chem Neurosci"},{"key":"3159_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1021\/acschemneuro.0c00615","volume":"12","author":"MG Fronza","year":"2021","unstructured":"Fronza MG, Baldinotti R, Sacramento M, Gutierres J, da CarvalhoFernandes FBMC, Sousa FSS, Seixas FK, Collares T, Alves D, Pratico D, Savegnago L (2021) Effect of QTC-4-MeOBnE treatment on memory, neurodegeneration, and neurogenesis in a streptozotocin-induced mouse model of Alzheimer\u2019s disease. ACS Chem Neurosci 12:109\u2013122","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"3159_CR28","doi-asserted-by":"publisher","first-page":"7276","DOI":"10.1038\/s41598-019-43532-9","volume":"9","author":"MG Fronza","year":"2019","unstructured":"Fronza MG, Baldinotti R, Martins MC, Goldani B, Dalberto BT, Kremer FS, Begnini K, da Pinto LS, Lenard\u00e3o EJ, Seixas FK, Collares T, Alves D, Savegnago L (2019) Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer\u2019s disease. Sci Rep 9(1):7276. https:\/\/doi.org\/10.1038\/s41598-019-43532-9","journal-title":"Sci Rep"},{"key":"3159_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-021-03514-8","author":"MG Fronza","year":"2022","unstructured":"Fronza MG, Sacramento M, Alves D, Pratic\u00f2 D, Savegnago L (2022) 1-(7-Chloroquinolin-4-yl)-N-(4-methoxybenzyl)-5-methyl-1H-1,2, 3-triazole-4-carboxamide reduces A\u03b2 formation and tau phosphorylation in cellular models of Alzheimer\u2019s disease. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-021-03514-8","journal-title":"Neurochem Res"},{"key":"3159_CR30","doi-asserted-by":"publisher","DOI":"10.1037\/h0062419","author":"KW Spence","year":"1946","unstructured":"Spence KW, Lippitt R (1946) An experimental test of the sign-gestalt theory of trial and error learning. J Exp Psychol. https:\/\/doi.org\/10.1037\/h0062419","journal-title":"J Exp Psychol"},{"key":"3159_CR31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730\u2013732","journal-title":"Nature"},{"key":"3159_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biopsych.2016.05.023","volume":"81","author":"A Di Meco","year":"2017","unstructured":"Di Meco A, Li J-G, Blass BE, Abou-Gharbia M, Lauretti E, Pratic\u00f2 D (2017) 12\/15-Lipoxygenase inhibition reverses cognitive impairment, brain amyloidosis, and tau pathology by stimulating autophagy in aged triple transgenic mice. Biol Psychiatry 81:92\u2013100. https:\/\/doi.org\/10.1016\/j.biopsych.2016.05.023","journal-title":"Biol Psychiatry"},{"key":"3159_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409\u2013421. https:\/\/doi.org\/10.1016\/s0896-6273(03)00434-3","journal-title":"Neuron"},{"key":"3159_CR34","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2174\/138161212799315786","volume":"18","author":"M Kitazawa","year":"2012","unstructured":"Kitazawa M, Medeiros R, Laferla FM (2012) Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions. Curr Pharm Des 18:1131\u20131147. https:\/\/doi.org\/10.2174\/138161212799315786","journal-title":"Curr Pharm Des"},{"key":"3159_CR35","doi-asserted-by":"publisher","first-page":"e12791","DOI":"10.1111\/acel.12791","volume":"17","author":"D Baglietto-Vargas","year":"2018","unstructured":"Baglietto-Vargas D, Prieto GA, Limon A, Forner S, Rodriguez-Ortiz CJ, Ikemura K, Ager RR, Medeiros R, Trujillo-Estrada L, Martini AC, Kitazawa M, Davila JC, Cotman CW, Gutierrez A, LaFerla FM (2018) Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer\u2019s disease. Aging Cell 17:e12791. https:\/\/doi.org\/10.1111\/acel.12791","journal-title":"Aging Cell"},{"key":"3159_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.brainres.2010.06.011","volume":"1348","author":"R Sterniczuk","year":"2010","unstructured":"Sterniczuk R, Antle MC, Laferla FM, Dyck RH (2010) Characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease: part 2 Behavioral and cognitive changes. Brain Res 1348:149\u2013155. https:\/\/doi.org\/10.1016\/j.brainres.2010.06.011","journal-title":"Brain Res"},{"issue":"1","key":"3159_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4061\/2010\/780102","volume":"2010","author":"K-J Oh","year":"2010","unstructured":"Oh K-J, Perez SE, Lagalwar S, Vana L, Binder L, Mufson EJ (2010) Staging of Alzheimer\u2019s pathology in triple transgenic mice: a light and electron microscopic analysis. Int J Alzheimers Dis 2010(1):24. https:\/\/doi.org\/10.4061\/2010\/780102","journal-title":"Int J Alzheimers Dis"},{"key":"3159_CR38","doi-asserted-by":"publisher","first-page":"e12873","DOI":"10.1111\/acel.12873","volume":"18","author":"R Belfiore","year":"2019","unstructured":"Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, Oddo S (2019) Temporal and regional progression of Alzheimer\u2019s disease-like pathology in 3xTg-AD mice. Aging Cell 18:e12873. https:\/\/doi.org\/10.1111\/acel.12873","journal-title":"Aging Cell"},{"key":"3159_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel E, Grieco SF, Jope RS (2015) Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 148:114\u2013131. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.016","journal-title":"Pharmacol Ther"},{"key":"3159_CR40","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/hmg\/dds533","volume":"22","author":"A Fuster-Matanzo","year":"2013","unstructured":"Fuster-Matanzo A, Llorens-Mart\u00edn M, Sirerol-Piquer MS, Garc\u00eda-Verdugo JM, Avila J, Hern\u00e1ndez F (2013) Dual effects of increased glycogen synthase kinase-3\u03b2 activity on adult neurogenesis. Hum Mol Genet 22:1300\u20131315. https:\/\/doi.org\/10.1093\/hmg\/dds533","journal-title":"Hum Mol Genet"},{"key":"3159_CR41","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1089\/scd.2013.0397","volume":"23","author":"J Ahn","year":"2014","unstructured":"Ahn J, Jang J, Choi J, Lee J, Oh S-H, Lee J, Yoon K, Kim S (2014) GSK3\u03b2, but not GSK3\u03b1, inhibits the neuronal differentiation of neural progenitor cells as a downstream target of mammalian target of rapamycin complex1. Stem Cells Dev 23:1121\u20131133. https:\/\/doi.org\/10.1089\/scd.2013.0397","journal-title":"Stem Cells Dev"},{"key":"3159_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1471-4159.2002.00939.x","volume":"82","author":"L Mai","year":"2002","unstructured":"Mai L, Jope RS, Li X (2002) BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J Neurochem 82:75\u201383","journal-title":"J Neurochem"},{"key":"3159_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbrc.2014.10.087","volume":"454","author":"V Gupta","year":"2014","unstructured":"Gupta V, Chitranshi N, You Y, Gupta V, Klistorner A, Graham S (2014) Brain derived neurotrophic factor is involved in the regulation of glycogen synthase kinase 3\u03b2 (GSK3\u03b2) signalling. Biochem Biophys Res Commun 454:381\u2013386. https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.087","journal-title":"Biochem Biophys Res Commun"},{"key":"3159_CR44","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mp.2012.168","volume":"18","author":"JH Ledo","year":"2013","unstructured":"Ledo JH, Azevedo EP, Clarke JR, Ribeiro FC, Figueiredo CP, Foguel D, De Felice FG, Ferreira ST (2013) Amyloid-\u03b2 oligomers link depressive-like behavior and cognitive deficits in mice. Mol Psychiatry 18:1053\u20131054. https:\/\/doi.org\/10.1038\/mp.2012.168","journal-title":"Mol Psychiatry"},{"key":"3159_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3389\/fphar.2019.00483","volume":"10","author":"MG Morgese","year":"2019","unstructured":"Morgese MG, Trabace L (2019) Monoaminergic system modulation in depression and Alzheimer\u2019s disease: a new standpoint? Front Pharmacol 10:483. https:\/\/doi.org\/10.3389\/fphar.2019.00483","journal-title":"Front Pharmacol"},{"key":"3159_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00635-0","author":"TM Satir","year":"2020","unstructured":"Satir TM, Agholme L, Karlsson A, Karlsson M, Karila P, Illes S, Bergstr\u00f6m P, Zetterberg H (2020) Partial reduction of amyloid \u03b2 production by \u03b2-secretase inhibitors does not decrease synaptic transmission. Alzheimer\u2019s Res Ther. https:\/\/doi.org\/10.1186\/s13195-020-00635-0","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"3159_CR47","doi-asserted-by":"publisher","DOI":"10.2174\/1567205012666141218140953","author":"R Baranello","year":"2015","unstructured":"Baranello R, Bharani K, Padmaraju V, Chopra N, Lahiri D, Greig N, Pappolla M, Sambamurti K (2015) Amyloid-beta protein clearance and degradation (ABCD) Pathways and their role in Alzheimer\u2019s disease. Curr Alzheimer Res. https:\/\/doi.org\/10.2174\/1567205012666141218140953","journal-title":"Curr Alzheimer Res"},{"key":"3159_CR48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JAD-170061","volume":"58","author":"X-Z Yuan","year":"2017","unstructured":"Yuan X-Z, Sun S, Tan C-C, Yu J-T, Tan L (2017) The role of ADAM10 in Alzheimer\u2019s disease. J Alzheimers Dis 58:303\u2013322. https:\/\/doi.org\/10.3233\/JAD-170061","journal-title":"J Alzheimers Dis"},{"key":"3159_CR49","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/neu.20257","volume":"66","author":"CL Hinkle","year":"2006","unstructured":"Hinkle CL, Diestel S, Lieberman J, Maness PF (2006) Metalloprotease-induced ectodomain shedding of neural cell adhesion molecule (NCAM). J Neurobiol 66:1378\u20131395. https:\/\/doi.org\/10.1002\/neu.20257","journal-title":"J Neurobiol"},{"key":"3159_CR50","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1523\/JNEUROSCI.4517-09.2010","volume":"30","author":"J Blundell","year":"2010","unstructured":"Blundell J, Blaiss CA, Etherton MR, Espinosa F, Tabuchi K, Walz C, Bolliger MF, S\u00fcdhof TC, Powell CM (2010) Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J Neurosci 30:2115\u20132129. https:\/\/doi.org\/10.1523\/JNEUROSCI.4517-09.2010","journal-title":"J Neurosci"},{"key":"3159_CR51","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1523\/JNEUROSCI.3699-13.2014","volume":"34","author":"M Klingener","year":"2014","unstructured":"Klingener M, Chavali M, Singh J, McMillan N, Coomes A, Dempsey PJ, Chen EI, Aguirre A (2014) N-cadherin promotes recruitment and migration of neural progenitor cells from the SVZ neural stem cell niche into demyelinated lesions. J Neurosci 34:9590\u20139606. https:\/\/doi.org\/10.1523\/JNEUROSCI.3699-13.2014","journal-title":"J Neurosci"},{"key":"3159_CR52","doi-asserted-by":"publisher","first-page":"31692","DOI":"10.1038\/srep31692","volume":"6","author":"J Xu","year":"2016","unstructured":"Xu J, de Winter F, Farrokhi C, Rockenstein E, Mante M, Adame A, Cook J, Jin X, Masliah E, Lee K-F (2016) Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer\u2019s disease model. Sci Rep 6:31692. https:\/\/doi.org\/10.1038\/srep31692","journal-title":"Sci Rep"},{"key":"3159_CR53","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.neurobiolaging.2006.11.004","volume":"29","author":"KFS Bell","year":"2008","unstructured":"Bell KFS, Zheng L, Fahrenholz F, Cuello AC (2008) ADAM-10 over-expression increases cortical synaptogenesis. Neurobiol Aging 29:554\u2013565. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.11.004","journal-title":"Neurobiol Aging"},{"key":"3159_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.neuron.2013.08.035","volume":"80","author":"J Suh","year":"2013","unstructured":"Suh J, Choi SH, Romano DM, Gannon MA, Lesinski AN, Kim DY, Tanzi RE (2013) ADAM10 missense mutations potentiate \u03b2-amyloid accumulation by impairing prodomain chaperone function. Neuron 80:385\u2013401. https:\/\/doi.org\/10.1016\/j.neuron.2013.08.035","journal-title":"Neuron"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03159-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-03159-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03159-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T11:01:56Z","timestamp":1675508516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-03159-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3159"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-03159-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was authorized by the Institutional Animal Care and Usage Committee and conducted in line with the principles of the National Institute of Health guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors agreed with the content and gave explicit consent to the formulation and publication of this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}